This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Sanofi-A Ventis Deutschland Gmbh. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 330 
1 out of 1,855 
Years Active: 2005-2009
Title: Heinz Gögelein: Innovator in Hyperpolarization-Activated Cation Channels
Introduction
Heinz Gögelein is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of hyperpolarization-activated cation channels. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Gögelein's latest patents focus on processes for identifying substances that modulate the activity of hyperpolarization-activated cation channels. These inventions provide valuable methodologies for discovering new compounds that can influence these channels, which are crucial in various physiological processes.
Career Highlights
Throughout his career, Heinz Gögelein has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
He has collaborated with notable colleagues such as Hans-Willi Jansen and Holger Heitsch, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Heinz Gögelein's work in the modulation of hyperpolarization-activated cation channels showcases his innovative spirit and dedication to advancing biochemistry. His patents and collaborations reflect a commitment to scientific progress and the potential for new therapeutic discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile